Plain-English translation of NCT05315141 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This is a long-term study that follows 500 patients diagnosed with ANCA-associated vasculitis β a condition where the immune system attacks small blood vessels β across five hospitals in Hunan Province, China. Researchers will collect information about your health, symptoms, lab results, and imaging scans at the start and then every year for at least five years. The goal is to understand how this disease develops and progresses, and what factors affect patient outcomes.
Very little is known about how blood vessel inflammation progresses in this region of China or what complications patients are most likely to face. This study will help doctors better predict which patients are at highest risk for serious problems like kidney failure or death, and may guide better treatment decisions in the future.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You will visit one of the five participating hospitals for an initial appointment where doctors will record your medical history, current medications, lifestyle habits, and take measurements and blood samples. After that, you will return once a year for similar check-ups and blood work for at least five years, or until your kidneys require dialysis, you pass away, or you choose to leave the study. The researchers will track how your disease changes over time and whether you develop serious complications.
AI-generated summary from trial data Β· Jul 14, 2026 Β· Not medical advice
China
Sponsor
Xiangya Hospital of Central South University
Collaborators
Central South University, The Third Xiangya Hospital of Central South University
Enrollment target
~500 participants
Started
March 2022
Primary completion
March 2027
Last updated on clinicaltrials.gov in April 2022.
Reach out to the team running this trial. Response times vary β some teams are faster than others.
Central contact
Yong Zhong, doctor
Xiangya Hospital of Central South University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first β no email needed to get started.